MediciNova(MNOV)
LA JOLLA, CABiotechnology
Focus: MediciNova is a public biotech focused on small-molecule therapeutics spanning respiratory, neurology, infectious diseases, oncology, and metabolic diseases. The company is in early-stage development with minimal revenue and a heavily R&D-weighted cost structure.
Profile data last refreshed 11h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About MediciNova
AI assessmentNot HiringNo open roles listed right now. Follow MediciNova to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from MediciNova's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
21 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$410K
Pipeline & Clinical Trials
MN-166
ALSClinical Trials (1)
NCT06743776Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS
N/AHelp build intelligence for MediciNova
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.